Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001641172-25-014569
Filing Date
2025-06-10
Accepted
2025-06-10 17:25:23
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 4872
  Complete submission text file 0001641172-25-014569.txt   6444
Mailing Address 17537 DARBY LANE LUTZ FL 33558
Business Address
Fell Donald G. (Reporting) CIK: 0001616905 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41293 | Film No.: 251038107

Mailing Address 194 CANDELARO DRIVE, #233 HUMACAO PR 00791
Business Address 194 CANDELARO DRIVE, #233 HUMACAO PR 00791 561-704-8527
Aspire Biopharma Holdings, Inc. (Issuer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)